Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析

◆英語タイトル:Basilea Pharmaceutica Ltd (BSLN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15068
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥33,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Basilea Pharmaceutica Ltd (Basilea) is a biopharmaceutical company that develops and markets antibiotics, antifungals and oncology drugs. The company’s products address increasing resistance and non-response to present treatment options for various therapeutic areas such as cancer, bacterial infections and fungal infections, among others. Basilea also conducts research in the areas of anti-infectives, cancer and bacterial or fungal strains. It discovers drugs with the help of various technologies such as genomics, assay development, cell biology, and others. The company also operates in France, the UK, China, Germany, Spain, Switzerland, Italy and Denmark. Basilea is headquartered in Basel, Switzerland.

Basilea Pharmaceutica Ltd Key Recent Developments

Feb 19,2019: Basilea reports strong revenue growth and significant pipeline progress for full-year 2018
Feb 08,2019: Strong European Cresemba isavuconazole sales trigger USD 5 million milestone payment to Basilea from Pfizer
Feb 07,2019: Basilea announces change in the Management Committee – Adesh Kaul appointed CFO
Jan 09,2019: Basilea reports positive interim results from registrational phase 2 study with oncology drug candidate derazantinib in intrahepatic cholangiocarcinoma (iCCA)
Jan 07,2019: Basilea reports strong, higher than expected preliminary revenue of CHF 133 million for financial year 2018

This comprehensive SWOT profile of Basilea Pharmaceutica Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Basilea Pharmaceutica Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Basilea Pharmaceutica Ltd – Key Information
Basilea Pharmaceutica Ltd – Overview
Basilea Pharmaceutica Ltd – Key Employees
Basilea Pharmaceutica Ltd – Key Employee Biographies
Basilea Pharmaceutica Ltd – Key Operational Heads
Basilea Pharmaceutica Ltd – Major Products and Services
Basilea Pharmaceutica Ltd – History
Basilea Pharmaceutica Ltd – Company Statement
Basilea Pharmaceutica Ltd – Locations And Subsidiaries
Basilea Pharmaceutica Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Basilea Pharmaceutica Ltd – Business Description
Basilea Pharmaceutica Ltd – Corporate Strategy
Basilea Pharmaceutica Ltd – SWOT Analysis
SWOT Analysis – Overview
Basilea Pharmaceutica Ltd – Strengths
Basilea Pharmaceutica Ltd – Weaknesses
Basilea Pharmaceutica Ltd – Opportunities
Basilea Pharmaceutica Ltd – Threats
Basilea Pharmaceutica Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Basilea Pharmaceutica Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Basilea Pharmaceutica Ltd, Key Information
Basilea Pharmaceutica Ltd, Key Ratios
Basilea Pharmaceutica Ltd, Share Data
Basilea Pharmaceutica Ltd, Major Products and Services
Basilea Pharmaceutica Ltd, History
Basilea Pharmaceutica Ltd, Key Employees
Basilea Pharmaceutica Ltd, Key Employee Biographies
Basilea Pharmaceutica Ltd, Key Operational Heads
Basilea Pharmaceutica Ltd, Other Locations
Basilea Pharmaceutica Ltd, Subsidiaries
Basilea Pharmaceutica Ltd, Key Manufacturing facilities
Basilea Pharmaceutica Ltd, Key Competitors
Basilea Pharmaceutica Ltd, SWOT Analysis
Basilea Pharmaceutica Ltd, Ratios based on current share price
Basilea Pharmaceutica Ltd, Annual Ratios
Basilea Pharmaceutica Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Basilea Pharmaceutica Ltd, Performance Chart
Basilea Pharmaceutica Ltd, Ratio Charts

★海外企業調査レポート[Basilea Pharmaceutica Ltd (BSLN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Proteostasis Therapeutics Inc (PTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteostasis Therapeutics Inc (Proteostasis) is a developer of therapies that discovers and develops therapeutics for the treatment of diseases related to defects in protein folding, trafficking and clearance. The company’s portfolio spans drug candidates for cystic fibrosis, neurodegenerati …
  • RPC Group PLC:企業のM&A・事業提携・投資動向
    RPC Group PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RPC Group PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Chubb Limited:企業の戦略・SWOT・財務情報
    Chubb Limited - Strategy, SWOT and Corporate Finance Report Summary Chubb Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Young & Co.’s Brewery, P.L.C. (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery, P.L.C. (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Forrester Research, Inc.
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • FlightSafety International Inc:企業の戦略・SWOT・財務分析
    FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report Summary FlightSafety International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Marina Biotech Inc (MRNA):製薬・医療:M&Aディール及び事業提携情報
    Summary Marina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using combination therapies of already approved drugs. The company is developing and …
  • Corporate Office Properties Trust:企業の戦略・SWOT・財務情報
    Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report Summary Corporate Office Properties Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers active pharmaceutical ingredients and bulk drugs used in anti-neoplastics. It offers products …
  • Z Energy Ltd
    Z Energy Ltd - Strategy, SWOT and Corporate Finance Report Summary Z Energy Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Credit Saison Co., Ltd.:企業のM&A・事業提携・投資動向
    Credit Saison Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Credit Saison Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Nasser S. Al –Hajri Corp:企業の戦略的SWOT分析
    Nasser S. Al –Hajri Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SuanFarma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary SuanFarma SA (SuanFarma Group) is a drug development company that offers production, development, and marketing of raw materials and finished dosage forms. The company’s products portfolio includes amoxiciline capsules, enalapril tablets, colistin methanesulphonate, azitromicine film coated …
  • PT Soho Global Health Tbk (SOHO):企業の財務・戦略的SWOT分析
    PT Soho Global Health Tbk (SOHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Colonial Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary Colonial Pipeline Co (Colonial) is an oil and gas company that distributes petroleum products. The company transports refined petroleum products such as gasoline, home-heating oil, kerosene, diesel fuels; and aviation fuel including jet fuel and military fuels. It provides services including …
  • Archroma Management LLC:企業の戦略的SWOT分析
    Archroma Management LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • AltaGas Ltd (ALA)-石油・ガス分野:企業M&A・提携分析
    Summary AltaGas Ltd. (AltaGas), is an energy utility. The company undertakes activities related to extraction, transmission, distribution and storage of natural gas. AltaGas generates electricity utilizing diverse fuel sources, such as wind, run-of-river hydro, geothermal and gas-fired generation pl …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • EDF Renewables Inc:企業の戦略的SWOT分析
    EDF Renewables Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • University of Oxford-製薬・医療分野:企業M&A・提携分析
    Summary University of Oxford (UO) is a research and educational university that offers student training, academic research and graduation programs. The university offers graduation courses in the various fields such as humanities, mathematical, physical and life sciences; medical sciences, and conti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆